Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Debt Ratio (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Debt Ratio for 4 consecutive years, with 0.0 as the latest value for Q3 2025.

  • On a quarterly basis, Debt Ratio rose 14.28% to 0.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0, a 14.28% increase, with the full-year FY2024 number at 0.0, changed N/A from a year prior.
  • Debt Ratio was 0.0 for Q3 2025 at bioAffinity Technologies, down from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.04 in Q3 2022 to a low of 0.0 in Q1 2024.
  • A 4-year average of 0.01 and a median of 0.0 in 2023 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: crashed 82.22% in 2024, then soared 203.32% in 2025.
  • bioAffinity Technologies' Debt Ratio stood at 0.02 in 2022, then plummeted by 76.91% to 0.0 in 2023, then crashed by 35.06% to 0.0 in 2024, then grew by 22.05% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Debt Ratio are 0.0 (Q3 2025), 0.01 (Q2 2025), and 0.01 (Q1 2025).